{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:14:51Z","timestamp":1762431291812,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jccase.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T21:01:04Z","timestamp":1492203664000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disopyramide as rescue treatment in a critically ill infant with obstructive hypertrophic cardiomyopathy refractory to beta blockers"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-435X","authenticated-orcid":false,"given":"Moises","family":"Rodriguez-Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Castellano-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislava","family":"Grujic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Azahara","family":"Prieto-Heredia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2017.03.004_bib0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/heartjnl-2011-300531","article-title":"Hypertrophic cardiomyopathy in children","volume":"98","author":"Moak","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jccase.2017.03.004_bib0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1472-8206.2010.00869.x","article-title":"Hypertrophic cardiomyopathy in childhood and adolescence \u2014 strategies to prevent sudden death","volume":"24","author":"\u00d6stman-Smith","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jccase.2017.03.004_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.pcad.2012.05.003","article-title":"Can pharmacologic gradient reduction decrease mortality in hypertrophic cardiomyopathy","volume":"54","author":"Musat","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jccase.2017.03.004_bib0020","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2017.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2014.02.022","article-title":"Advances in medical treatment of hypertrophic cardiomyopathy","volume":"64","author":"Hamada","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jccase.2017.03.004_bib0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with \u03b2-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jccase.2017.03.004_bib0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1047951114000237","article-title":"Effects of lifestyle changes and high-dose \u03b2-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy","volume":"25","author":"Bratt","year":"2015","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jccase.2017.03.004_bib0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcad.2012.04.003","article-title":"A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jccase.2017.03.004_bib0045","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.amjcard.2010.06.059","article-title":"Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline","volume":"106","author":"Kajimoto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jccase.2017.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1378\/chest.07-1188","article-title":"Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting","volume":"133","author":"Sirak","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jccase.2017.03.004_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug and non-drug-associated QT interval prolongation","volume":"70","author":"Van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540917300282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540917300282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:10:06Z","timestamp":1761804606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540917300282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1878540917300282"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2017.03.004","relation":{},"ISSN":["1878-5409"],"issn-type":[{"type":"print","value":"1878-5409"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disopyramide as rescue treatment in a critically ill infant with obstructive hypertrophic cardiomyopathy refractory to beta blockers","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}